Ting C C, Law L W
J Immunol. 1977 Apr;118(4):1259-64.
H-2 dependency of T cell-mediated cytotoxicity and transplantation immunity to leukemia-associated antigens has been investigated. Through the use of a 20-hr 125IUdR release assay, it was found that the induction of T cell-mediated cytotoxicity against Friend virus-induced leukemias of different H-2 haplotype orgins could be produced by immunization with both syngeneic and allogeneic tumor cells; the effector cells that were generated by syngeneic immunization could also provide effective killing of allogeneic tumor cells, although the killing of allogeneic targets might require a longer incubation time (20 to 40 hr). Furthermore, in vivo transplantation immunity against Friend virus-induced leukemias also was induced by immunization with both syngeneic and allogeneic tumors and syngeneic immunization could induce specific protection against the challenge with a-logeneic tumor in x-irradiated hosts. These findings clearly indicate that, both at the sensitizing phase and effector phase of the immune response, there is no strict H-2 dependency for T cell-mediated cytotoxicity or in in vivo transplantation imunity to leukemia-associated antigens.
已经研究了T细胞介导的细胞毒性和对白血病相关抗原的移植免疫的H-2依赖性。通过使用20小时的125IUdR释放试验,发现用同基因和异基因肿瘤细胞免疫均可诱导针对不同H-2单倍型起源的Friend病毒诱导的白血病的T细胞介导的细胞毒性;同基因免疫产生的效应细胞也能有效杀伤异基因肿瘤细胞,尽管杀伤异基因靶细胞可能需要更长的孵育时间(20至40小时)。此外,用同基因和异基因肿瘤免疫也可诱导对Friend病毒诱导的白血病的体内移植免疫,并且同基因免疫可在X射线照射的宿主中诱导针对异基因肿瘤攻击的特异性保护。这些发现清楚地表明,在免疫反应的致敏阶段和效应阶段,T细胞介导的细胞毒性或对白血病相关抗原的体内移植免疫均不存在严格的H-2依赖性。